Breaking News Instant updates and real-time market news.

TSLA

Tesla

$242.09

-0.48 (-0.20%)

, GM

General Motors

$37.42

-0.2 (-0.53%)

07:32
09/30/19
09/30
07:32
09/30/19
07:32

Potential value of Tesla emissions credits 'underappreciated,' says Oppenheimer

With Tesla (TSLA) reporting Q3 deliveries this week, Oppenheimer analyst Colin Rusch believes the company is working aggressively to reach its fiscal year 2019 volume guidance of 360k-400k units. If it achieves 100k deliveries in Q3, it would need 101.7k vehicles to reach the low end of that guidance, which he believes is ahead of Street expectations. Rusch also thinks demand in Europe remains strong, driven partially by emissions regulations, and believes investors underappreciate the potential value of Tesla emissions credits as OEMs continue to lag schedules for new energy vehicle availability. At the same time, the analyst continues to watch the impact of General Motors' (GM) strike, as he believes many of the issues facing the company are endemic in the industry and sees the issues for legacy OEMs helping extending Tesla's window of opportunity for taking share.

TSLA

Tesla

$242.09

-0.48 (-0.20%)

GM

General Motors

$37.42

-0.2 (-0.53%)

TSLA Tesla
$242.09

-0.48 (-0.20%)

09/26/19
FBCO
09/26/19
NO CHANGE
Target $189
FBCO
Underperform
Credit Suisse sees potential upside to Tesla Q3 delivery estimate
With Tesla expected to release Q3 deliveries next week, Credit Suisse analyst Dan Levy says that his currently published estimate of 84k is below consensus of about 96k, and also below the 100k pace necessary through the end of the year to meet 2019 delivery guidance. While Tesla would likely need yet another strong third month of the quarter to meet consensus, nevertheless, it would not surprise him to see Tesla put up the volumes in September. That said, even if it meets consensus on deliveries, the analyst believes the question into Q3 EPS will be around margins plus how the stock reacts with likely the first negative year over year revenue growth quarter since 2012. Levy has an Underperform rating and $189 price target on the shares.
09/26/19
CHRS
09/26/19
INITIATION
Target $324
CHRS
Buy
Tesla initiated with a Buy at China Renaissance
China Renaissance analyst Carson Ng initiated Tesla with a Buy rating and $324 price target.
09/26/19
CHRS
09/26/19
INITIATION
Target $324
CHRS
Buy
Tesla 'immune' to China subsidy cuts, says China Renaissance
China Renaissance analyst Carson Ng initiated Tesla with a Buy rating and $324 price target. In a research note to investors, Ng contends that NEV sales growth in China in the second half of the year will be impacted by the subsidy cut and loosening of car purchase restrictions on commercial vehicles, but believes Tesla is immune since it has never enjoyed any China government subsidies. Ng says he is positive on Tesla's outlook in China and expects its exemption from the 10% car purchase tax and commencement of local production this year to drive deliveries in the country to 135,000 units in 2021E from 13,000 units in 2018E.
09/26/19
BARD
09/26/19
NO CHANGE
Target $355
BARD
Outperform
Tesla expectations into Q3 deliveries data is low, says Baird
Baird analyst Ben Kallo said the Tesla expectations ahead of its Q3 deliveries release is low but he likes the setup into the data. The analyst believes the shares will react positively if the company can achieve 95+ deliveries. He notes investors are focused on margins which he thinks will improve over the next few quarters. Kallo maintained his Outperform rating and $355 price target on Tesla shares.
GM General Motors
$37.42

-0.2 (-0.53%)

09/06/19
RILY
09/06/19
NO CHANGE
Target $7.5
RILY
Buy
TeleNav could be attractive buyout candidate at these levels, says B. Riley FBR
While news that General Motors (GM) is introducing new in-vehicle technology provided by Google (GOOG, GOOGL) is "clearly disappointing," any potential financial impact to Telenav (TNAV) is unlikely to happen until fiscal 2022, B. Riley FBR analyst Josh Nichols tells investors in a research note. Further, the analyst believes TeleNav's revenue from GM is more likely to experience a gradual attrition over a number of years, giving the company a "long runway" to win additional business. Nichols lowered his price target for TeleNav shares to $7.50 from $10.50 but keeps a Buy rating on the name, believing most of the longer-term GM risk is already priced in, despite the eventual outcome remaining unclear. The stock closed Thursday down 45%, or $4.69, to $5.80. TeleNav's current enterprise value of approximately $150M could potentially be justified by Ford (F) alone, which accounted for $141M of billings in fiscal 2019, says Nichols. In addition, TeleNav has developed an array of automotive relationships expertise, and intellectual property, which "has value as well and could be attractive to potential buyers at these levels," contends the analyst.
09/16/19
09/16/19
UPGRADE
Target $15

Buy
Cars.com upgraded to Buy on attractive valuation, GM approval at Craig-Hallum
As previously reported, Craig-Hallum analyst Steve Dyer upgraded Cars.com (CARS) to Buy from Hold, with a $15 price target, as he thinks shares are mostly de-risked following the "massive" selloff after the conclusion of the company's strategic review. Further, the analyst believes that estimate cuts are largely done for the first time since the spin-out, and thinks the company's "strong" free cash flow is underappreciated. The announcement by General Motors (GM) to approve Dealer Inspire as an optional website services provider for its 4k dealers could be a catalyst for shares, he adds.
09/19/19
LOOP
09/19/19
NO CHANGE
Target $104
LOOP
Buy
Ingevity fundamentals not undermined by UAW strike, says Loop Capital
Loop Capital analyst Chris Kapsch keeps his Buy rating and $104 price target on Ingevity (NGVT), saying the underpinnings of his recent upgrade remain intact even though the stock price has pulled back about 4% over the past few days. The analyst notes that the retreat was likely driven by concerns about General Motors' (GM) UAW strike and the attempts by the Trump administration to revoke auto emission regulation in California, but believes that these developments do not alter the overall fundamental story for the stock. Kapsch adds that he would be inclined to buy into any additional pressure on Ingevity shares.
09/23/19
BUCK
09/23/19
NO CHANGE
Target $35
BUCK
Neutral
GM likely to face longer-term work stoppage as strike drags on, says Buckingham
Buckingham analyst Joseph Amaturo maintained a Neutral rating and $35 price target on GM as the UAW strike enters its second week and reiterated his view that an extended stoppage is "likely." In a research note to investors, Amaturo says he believes GM has "no choice" but to settle for unfavorable terms, as political consensus has firmly sided with the UAW workers publicly, granting them sympathy and the moral high ground from President Trump and the Democrats. With the stock trading lower by just under 4% last week, the analyst says he believes that the shares could come under additional pressure as investors realize that this will be a longer-term work stoppage after one full week of negotiating without a settlement.

TODAY'S FREE FLY STORIES

PFGC

Performance Food Group

$44.66

-0.13 (-0.29%)

20:19
11/20/19
11/20
20:19
11/20/19
20:19
Syndicate
Performance Food Group 10.12M share Secondary priced at $44.25 »

Wells Fargo and Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

ALPMY

Astellas Pharma

$0.00

(0.00%)

20:02
11/20/19
11/20
20:02
11/20/19
20:02
Hot Stocks
Astellas Pharma, Welldoc enter into Digital Therapeutics alliance »

Astellas Pharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PYPL

PayPal

$104.09

-0.85 (-0.81%)

19:52
11/20/19
11/20
19:52
11/20/19
19:52
Recommendations
PayPal analyst commentary  »

PayPal's Honey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 10

    Dec

SQM

SQM

$23.41

-0.35 (-1.47%)

19:42
11/20/19
11/20
19:42
11/20/19
19:42
Earnings
SQM reports Q3 EPS 23c, consensus 26c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TNAV

TeleNav

$4.92

0.07 (1.44%)

19:37
11/20/19
11/20
19:37
11/20/19
19:37
Hot Stocks
TeleNav CEO buys 150K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CRSP

Crispr Therapeutics

$67.31

-1.15 (-1.68%)

19:29
11/20/19
11/20
19:29
11/20/19
19:29
Syndicate
Breaking Syndicate news story on Crispr Therapeutics »

Crispr Therapeutics 4.25M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 21

    Nov

PFGC

Performance Food Group

$44.66

-0.13 (-0.29%)

19:26
11/20/19
11/20
19:26
11/20/19
19:26
Syndicate
Performance Food Group upsized 10.1M share offering said to price at $44.25 »

Report from Bloomberg. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

INVH

Invitation Homes

$30.05

0.13 (0.43%)

19:10
11/20/19
11/20
19:10
11/20/19
19:10
Periodicals
Breaking Periodicals news story on Invitation Homes »

Invitation Homes stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

KRTX

Karuna Therapeutics

$108.42

-15.58 (-12.56%)

19:03
11/20/19
11/20
19:03
11/20/19
19:03
Syndicate
Karuna Therapeutics 2.6M share Secondary priced at $96.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

GOOG

Alphabet

$1,302.26

-12.45 (-0.95%)

, GOOGL

Alphabet Class A

$1,301.34

-11.25 (-0.86%)

18:58
11/20/19
11/20
18:58
11/20/19
18:58
Hot Stocks
Google to limit election ads audience targeting, will prohibit 'deep fakes' »

Alphabet's Google…

GOOG

Alphabet

$1,302.26

-12.45 (-0.95%)

GOOGL

Alphabet Class A

$1,301.34

-11.25 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAN

Canaan

$0.00

(0.00%)

18:56
11/20/19
11/20
18:56
11/20/19
18:56
Syndicate
Canaan 10M share IPO priced at $9.00 »

The deal priced at low…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

NUAN

Nuance

$16.60

0.11 (0.67%)

, CPRT

Copart

$84.69

-1.64 (-1.90%)

18:51
11/20/19
11/20
18:51
11/20/19
18:51
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Nuance…

NUAN

Nuance

$16.60

0.11 (0.67%)

CPRT

Copart

$84.69

-1.64 (-1.90%)

LB

L Brands

$16.00

-1.19 (-6.92%)

JACK

Jack in the Box

$84.89

-0.08 (-0.09%)

SONO

Sonos

$13.87

-0.635 (-4.38%)

NTGN

Neon Therapeutics

$1.44

-0.04 (-2.70%)

TIF

Tiffany

$123.32

-0.16 (-0.13%)

UBER

Uber

$28.02

0.99 (3.66%)

LZB

La-Z-Boy

$36.23

-0.265 (-0.73%)

CUB

Cubic

$73.63

0.8 (1.10%)

NTES

NetEase

$287.68

-1.09 (-0.38%)

OPTN

Optinose

$11.42

0.84 (7.94%)

MTEM

Molecular Templates

$8.28

0.19 (2.35%)

PYPL

PayPal

$104.09

-0.85 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 04

    Dec

  • 05

    Dec

  • 05

    Dec

  • 06

    Dec

  • 10

    Dec

  • 10

    Dec

  • 21

    Nov

  • 21

    Nov

WNC

Wabash

$15.05

-0.2 (-1.31%)

18:48
11/20/19
11/20
18:48
11/20/19
18:48
Initiation
Wabash initiated  »

Wabash initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALSN

Allison Transmission

$45.51

-0.56 (-1.22%)

18:47
11/20/19
11/20
18:47
11/20/19
18:47
Initiation
Allison Transmission initiated  »

Allison Transmission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAV

Navistar

$30.97

-0.97 (-3.04%)

18:47
11/20/19
11/20
18:47
11/20/19
18:47
Initiation
Navistar initiated  »

Navistar initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCAR

Paccar

$78.85

-0.59 (-0.74%)

18:47
11/20/19
11/20
18:47
11/20/19
18:47
Initiation
Paccar initiated  »

Paccar initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMI

Cummins

$180.59

-2.36 (-1.29%)

18:46
11/20/19
11/20
18:46
11/20/19
18:46
Initiation
Cummins initiated  »

Cummins initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

VMC

Vulcan Materials

$140.72

-0.485 (-0.34%)

18:45
11/20/19
11/20
18:45
11/20/19
18:45
Initiation
Vulcan Materials initiated  »

Vulcan Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUM

Summit Materials

$24.18

0.3 (1.26%)

18:45
11/20/19
11/20
18:45
11/20/19
18:45
Initiation
Summit Materials initiated  »

Summit Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

MLM

Martin Marietta

$263.10

1.36 (0.52%)

18:45
11/20/19
11/20
18:45
11/20/19
18:45
Initiation
Martin Marietta initiated  »

Martin Marietta initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$31.36

-0.38 (-1.20%)

18:33
11/20/19
11/20
18:33
11/20/19
18:33
Hot Stocks
Tenet General Counsel sells 65K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFPT

Proofpoint

$119.56

1.25 (1.06%)

18:23
11/20/19
11/20
18:23
11/20/19
18:23
Hot Stocks
Proofpoint's Salle sells 10,479 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

LVMUY

LVMH

$0.00

(0.00%)

, TIF

Tiffany

$123.32

-0.16 (-0.13%)

18:21
11/20/19
11/20
18:21
11/20/19
18:21
Periodicals
Tiffany gives LVMH access to its books after raised bid, Reuters says »

LVMH (LVMUY) has…

LVMUY

LVMH

$0.00

(0.00%)

TIF

Tiffany

$123.32

-0.16 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CPRT

Copart

$84.69

-1.64 (-1.90%)

18:05
11/20/19
11/20
18:05
11/20/19
18:05
Earnings
Copart reports Q1 non-GAAP EPS 65c, consensus 59c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 06

    Dec

NTES

NetEase

$287.68

-1.09 (-0.38%)

18:04
11/20/19
11/20
18:04
11/20/19
18:04
Earnings
NetEase reports Q3 adjusted ADS $5.12, consensus $3.12 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.